Citi keeps a Neutral rating on Fortrea (FTRE) with a $6 price target after adding a “downside 90-day short-term view” on the shares. Citi is cautious on Fortrea, citing the softer demand environment amid biotech delays in funding.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FTRE:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue